HomeREGULATORY
REGULATORY

MHLW Study Group on Counterfeit Drugs to Discuss Issues such as GDP Later This Fiscal Year
(Jun.12.2017)

The Ministry of Health, Labor and Welfare’s (MHLW) study group on counterfeit drugs completed its discussions in the first half of the current fiscal year by approving a draft interim report on June 8. In later this fiscal year, it will reconvene to take up items requiring additional or long-term discussions, such as domestic rules to ensure greater harmony with PIC/S GDP guidelines ...
(LOG IN FOR FULL STORY)

News Calendar